Name | TLR2-IN-C29 |
---|---|
Synonyms | C29 |
Description | C29 is a Toll-like receptor 2 (TLR2) inhibitor. |
---|---|
Related Catalog | |
Target |
TLR2[1] |
In Vitro | C29 blunts hTLR2/1 and hTLR2/6 signaling in HEK-TLR2 Stable transfectants and THP-1 Cells. C29 blocks P3C- and P2C-induced IL-8 mRNA dose-dependently in HEK-TLR2 stable transfectants. C29 also inhibits P3C- and P2C-induced IL-1β gene expression significantly at both 1 h and 4 h following stimulation, as well as both P3C- and P2C-induced NF-κB–luciferase activity in transiently transfected HEK293T cells expressing hTLR2 and an NF-κB–sensitive luciferase reporter construct. C29 preferentially inhibits TLR2/1 signaling in primary murine macrophages. C29 blocks TLR2 bacterial agonist-induced proinflammatory gene expression in HEK-TLR2 Cells and murine macrophages. C29 inhibits ligand-induced interaction of TLR2 with MyD88 and blocks MAPK and NF-κB activation[1]. |
References |
[1]. Vogel S, et al. Small molecule inhibitors of tlr2 signaling. WO2016164414A1 |
Molecular Formula | C16H15NO4 |
---|---|
Molecular Weight | 285.2988 |
Storage condition | 2-8℃ |